PepGen (PEPG) Operating Leases (2022 - 2026)
PepGen (PEPG) reported Operating Leases of $13.4 million for Q1 2026, down 11.92% on a YoY basis from $15.2 million in Q1 2025, and down 3.37% sequentially from $13.8 million in Q4 2025.
PepGen (PEPG) Operating Leases (2022 - 2026) Analysis & Trends
PepGen (PEPG) has 5 years of Operating Leases data on file, last reported at $13.4 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Leases fell 11.92% year-over-year to $13.4 million; the trailing twelve-month figure through Mar 2026 stood at $13.4 million (down 11.92% YoY), and the FY2025 full-year result was $13.8 million, down 11.24% from the prior year.
- Operating Leases retreated to $13.4 million in Q1 2026, from $13.8 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $19.0 million in Q4 2022 to a low of $13.4 million in Q1 2026.
- A 5-year average of $16.1 million and a median of $16.2 million in 2024 frame the typical range for Operating Leases.
- Across the five-year window, Operating Leases retreated 7.86% in 2024 and fell 11.92% in 2026, its largest moves.
- Tracing PEPG's Operating Leases over 5 years: stood at $19.0 million in 2022, then retreated by 9.91% to $17.1 million in 2023, then fell by 8.96% to $15.6 million in 2024, then retreated by 11.24% to $13.8 million in 2025, then declined by 3.37% to $13.4 million in 2026.
- Business Quant data shows PEPG's Operating Leases at $13.4 million in Q1 2026, $13.8 million in Q4 2025, and $14.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | PepGen | 145.09 Mn | 145.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.35 Mn |
| Dec 31, 2025 | 13.82 Mn |
| Sep 30, 2025 | 14.28 Mn |
| Jun 30, 2025 | 14.72 Mn |
| Mar 31, 2025 | 15.16 Mn |
| Dec 31, 2024 | 15.57 Mn |
| Sep 30, 2024 | 15.97 Mn |
| Jun 30, 2024 | 16.36 Mn |
| Mar 31, 2024 | 16.74 Mn |
| Dec 31, 2023 | 17.10 Mn |
| Sep 30, 2023 | 17.45 Mn |
| Jun 30, 2023 | 17.87 Mn |
| Mar 31, 2023 | 18.17 Mn |
| Dec 31, 2022 | 18.98 Mn |